HIV Support & Immune Restoration Protocol
HIV Support & Immune Restoration Protocol framework focused on consistent execution, practical monitoring, and safer progression.
A supportive protocol for people living with HIV on stable antiretroviral therapy (ART), addressing residual immune activation, HIV-associated neurocognitive disorders (HAND), peripheral neuropathy, lean mass wasting, and accelerated aging phenotypes.
Who it's for
Use this as an educational framework with clinical oversight. Keep timing consistent, track response daily, and change one variable at a time after trend review. Pair protocol use with sleep, nutrition, and recovery fundamentals.
Free Peptide Guide
HIV Support & Immune Restoration Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Protocol at a Glance
Cycle Duration
Thymosin Alpha-1 induction x28 days, then maintenance 3x/week ongoing. All other compounds continuous.
Target Audience
Adults living with HIV on stable ART with immune activation, neuropathy, wasting, or accelerated aging concerns. Coordinate with HIV specialist.
| Compound | Dose | Frequency |
|---|---|---|
| Thymosin Alpha-1 Thymosin Alpha-1: most validated immune peptide in HIV; restores CD4+ T cell differentiation; improves cytokine balance and reduces chronic immune activation | 1.6 mg | Daily SC x 28 days, then 3x/week maintenance |
| Thymalin Thymalin: thymic polypeptide complex; restores thymic microenvironment and T cell maturation impaired by HIV-mediated thymic involution | 1–5 mg | Daily SC for 10-day cycles, 2–4x/year |
| LL-37 LL-37: demonstrates direct anti-HIV activity; modulates mucosal innate immunity; reduces opportunistic infection risk in patients with impaired mucosal barriers | 100–500 mcg | Daily SC |
| ARA-290 ARA-290: non-hematopoietic EPO receptor agonist; treats HIV-associated peripheral neuropathy and HAND-related neuroinflammation without ART interactions | 2–4 mcg/kg | Daily SC |
| Ipamorelin Ipamorelin: counteracts HIV wasting syndrome and lipodystrophy from protease inhibitors; restores GH pulsatility without IGF-1 excess | 200 mcg | Daily SC |
| NAD+ NAD+: repairs NRTI-associated mitochondrial toxicity in muscle, liver, and neurons; SIRT1 activation reduces chronic NF-κB-driven immune activation | 500 mg NMN | Once daily oral |
Free Peptide Guide
HIV Support & Immune Restoration Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.
Daily Schedule
Morning
Baseline review and first execution window
Log sleep, energy, and tolerance; complete planned Thymosin Alpha-1 timing if scheduled.
Midday
Adherence and symptom check
Review hydration, workload, and side effects before any changes.
Evening
Recovery closeout and next-day setup
Record outcomes, maintain schedule consistency, and prepare next-day protocol.
Safety
- Escalating side effects or new concerning symptoms require prompt clinical review.
- Avoid abrupt multi-compound changes during unstable periods.
- Maintain regular follow-up with a licensed clinician throughout the cycle.
Not appropriate for unsupervised use or as a replacement for diagnosis and medical care. Use only within a clinician-guided plan.
Who should avoid
- Anyone using this protocol without qualified medical supervision
- People with unstable medical or psychiatric conditions without specialist guidance
- Pregnant or breastfeeding individuals unless explicitly cleared by a physician
Common Mistakes
Changing multiple variables at once
Why it matters: This makes it hard to identify what improved outcomes versus what increased side effects.
How to fix: Keep one-variable changes per review cycle and log response for several days.
Ignoring adherence and recovery fundamentals
Why it matters: Protocol effectiveness drops when sleep, nutrition, and routine consistency are unstable.
How to fix: Protect daily anchors first, then optimize protocol details gradually.
FAQ
How long should HIV Support & Immune Restoration Protocol run before reassessment?
A common window is Thymosin Alpha-1 induction x28 days, then maintenance 3x/week ongoing. All other compounds continuous., with periodic review of tolerance and objective trends.
Can I increase complexity quickly for faster results?
Usually no. Safer optimization comes from staged changes and clear tracking.
What should I track each day?
Track schedule adherence, symptoms, sleep quality, and any adverse effects in one log.
Key Takeaways
- Consistency with Thymosin Alpha-1 + Thymalin execution matters more than frequent protocol changes.
- Single-variable adjustments improve safety and decision quality.
- Objective daily tracking supports better long-term outcomes.
Why This Stack Works
Despite effective ART, HIV causes chronic immune activation, accelerated biological aging, mitochondrial toxicity from nucleoside analogues, peripheral neuropathy, and HIV-associated neurocognitive disorders (HAND). Thymosin Alpha-1 is the most validated peptide in HIV — it restores thymic output, enhances CD4+ T cell differentiation, and improves cytokine profiles in immune reconstitution. Thymalin provides complementary thymic restoration through polypeptide thymic extract. LL-37 demonstrates direct antiviral activity against HIV while modulating innate immune responses in mucosal tissue. ARA-290 addresses the peripheral neuropathy affecting 30–50% of people with HIV without interacting with ART. Ipamorelin counteracts the HIV wasting syndrome and lipodystrophy from protease inhibitors. NAD+ repairs the mitochondrial damage caused by nucleoside reverse transcriptase inhibitors.
Clinical Research
No clinical references were provided for this stack yet.
More Immune Support Stacks
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
An adjunctive protocol for individuals with ankylosing spondylitis and axial spondyloarthropathy, targeting the IL-17/IL-23-driven enthesitis, progressive syndesmophyte formation, and the TNF-driven inflammatory cascade that cause irreversible spinal fusion.
Ankylosing Spondylitis & Axial Spondyloarthropathy Protocol
Anti-inflammatory and joint-protective peptide protocol for ankylosing spondylitis targeting spinal inflammation, syndesmophyte prevention, and preservation of spinal mobility.
Crohn's Disease & IBD Management Protocol
Peptide-based protocol targeting intestinal inflammation, barrier repair, and mucosal immune regulation for Crohn's disease and ulcerative colitis management.
Medical disclaimer: This protocol is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.
Free Peptide Guide
HIV Support & Immune Restoration Protocol Protocol PDF
Schedule template, practical checkpoints, common mistakes, and safety guidance in one quick reference.
Free access. No spam. This form sends the shared peptide guide that is live today.